Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts.

ABSTRACT:

SUBMITTER: Reis B 

PROVIDER: S-EPMC5004378 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature